Lung Cancer Screening: An Update

摘要: Two prominent and timely issues in lung cancer screening are discussed this article. First, findings from extended mortality follow-up of participants enrolled as part the Mayo Lung Project reviewed. These suggest that overdiagnosis-the identification, through screening, clinically unimportant lesions-may occur when for cancer. Second, question whether sufficient evidence exists to advocate mass with low radiation dose spiral computed tomography (CT) is discussed. Given absence data CT, it concluded such activities should not be advocated at point time. The Screening Study, an ongoing randomized controlled trial also described.